Hanmi Pharm. Co., Ltd. (128940.KS) KSC

356,250.00

+10250(+2.96%)

Updated at October 20 10:22AM

Currency In KRW

Valuation

Market Cap3.56T
Enterprise Value3.86T
P/E Ratio42.47
PEG Ratio-29.53
Price/Sales Ratio2.99
Price/Book Ratio4.12
Enterprise/Revenue3.24
Enterprise/EBITDA12.82

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.07
Operating Margin0.14

Management Effectiveness

Return On Assets0.06
Return On Equity0.1

Income Statement

Revenue1.5T
Revenue/Share109,176.25
Gross Profit817.04B
EBITDA292.96B
Net Income121.32B
Diluted EPS9,567.28

Balance Sheet

Total Cash188.04B
Total Cash/Share10,134.91
Total Debt440.19B
Total Debt/Equity0.39
Current Ratio1.24
Book Value Per Share95,309.59

Price History

52-Week Change0.14
52-Week High396,500
52-Week Low214,500
Moving Average 50 Days321,380
Moving Average 200 Days280,400

Statistics

Average Volume79,498
Shares Outstanding12.68M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1,250
Trailing Annual Dividend Yield0.36
Payout Ratio0.34
Last Split Factor51:50
Last Split DateDecember 27, 2023